Alpharma Seeks To Remove Stay On Generic Neurontin Approval
Company would launch gabapentin capsules "at risk" if stay on approval were lifted. The stay has been imposed because of dispute with Apotex regarding first-to-file exclusivity.
Company would launch gabapentin capsules "at risk" if stay on approval were lifted. The stay has been imposed because of dispute with Apotex regarding first-to-file exclusivity.